Scinovex
article Open Access

Assessment of efficacy of methotrexate and acitretin in the management of psoriasis

Abstract

Background: Psoriasis is a chronic inflammatory skin disease characterized by a prominent T-cell infiltrate, epidermal hyper proliferation and abnormal keratinocyte differentiation. The present study was conducted to assess efficacy of methotrexate and acitretin in the management of psoriasis.Materials & Methods: 72 patients diagnosed with palmoplantar psoriasis were divided into 2 groups of 36 each. Group I patients were prescribed oral methotrexate15mg/week for 3 months and group II were given oral acitretin 0.5 mg/kg daily for 3 months. Modified psoriasis area severity index (MPASI) score was assessed.Results: There were 16 males and 20 females in group I and 18 males and 18 females in group II. The mean MASI score at baseline, 1 month, 2 months and 3 months was 58.2, 38.4, 23.2 and 14.6 and 60.4, 40.2, 30.5 and 20.4 in group I and II respectively. The difference was significant (P

Psoriasis: Treatment and PathogenesisSynthesis and biological activityRetinoids in leukemia and cellular processesAcitretinPsoriasisMethotrexateMedicinePsoriasis Area and Severity IndexDermatologyEtretinateGastroenterologyInternal medicine
Citations
0
FWCI
0.00
field-weighted impact
References
10
Percentile
22%
vs. same field & year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Assessment of efficacy of methotrexate and acitretin in the management of psoriasis · Scinovex